EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Squamous cell carcinoma arising in chronically damaged skin (Marjolin’s Ulcer): still an unmet need in the era of immunotherapy

Mor Miodovnik iD, Yardenna Dolev, Roni Buchen, Miriam Rivka Brezis, Alla Nikolaevski-Berlin, Inbar Finkel, Ido Wolf, Inna Ospovat, Orit Gutfeld, Yasmin Leshem iD

The Oncologist · 2025

DOI: 10.1093/oncolo/oyae326 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Mor Miodovnik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Skin Neoplasms, Immunotherapy, Skin Ulcer. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cutaneous squamous cell carcinoma (cSCC) is characterized by a high tumor mutational burden due to solar damage and a favorable response to anti-PD-1 immunotherapy. Yet, we encounter tumors arising in areas with minimal sun exposure, such as cSCC that develops in chronically inflamed skin, also known as Marjolin’s Ulcer (MU). The response of MU-SCC to immunotherapy remains unknown.

Methods

We performed a retrospective analysis of patients diagnosed with cSCC and treated with cemiplimab or pembrolizumab in a single tertiary medical center. Patients lost to follow up were excluded.

Results

Of the 84 eligible patients, 9 (11%) had MU-SCC. Of these, 2 (22%) reached partial response (PR), and none reached complete response (CR). In contrast, of the 75 patients with solar damage-related cSCC, 40 had PR (53%), and 20 had CR (26%). The difference between the two subtypes was significant (P < .001). Interestingly, 3 patients with MU-SCC received a second-line chemo-immunotherapy and experienced a partial response that continued for 5 to 21 months. Patients with MU-SCC had a significantly shorter median time to progression (TTP) (1.6 vs 51.6 months, P < .001) and progression-free survival (PFS) (1.6 vs 15.4 months, P < .001). Overall survival (OS) was not significantly shorter (17.4 vs 36.7 months, P = .096). Multivariate analysis confirmed that MU-SCC is an independent risk factor for shorter TTP (HR 5.5, 95% CI 2.2-14.0, P < .001) and PFS (HR 3.5, 95% CI 1.5-8.1, P = .003).

Conclusions

This study suggests that immunotherapy is less beneficial in SCC-MU. More work is needed to verify our findings and explore other treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellSkin NeoplasmsImmunotherapySkin UlcerHumansFemaleMaleAgedRetrospective StudiesMiddle AgedAged, 80 and overAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

PD-1cutaneous squamous cell carcinomaimmunotherapymarjolin’s ulcer

Substanzen

pembrolizumabAntibodies, Monoclonal, Humanizedcemiplimab

Autor:innen und Institutionen

  • Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.

ORCID-Profile: Mor Miodovnik, Yasmin Leshem

Zitieren

APA

Miodovnik, M., Dolev, Y., Buchen, R., Brezis, M. R., Nikolaevski-Berlin, A., Finkel, I., Wolf, I., Ospovat, I., Gutfeld, O., & Leshem, Y. (2025). Squamous cell carcinoma arising in chronically damaged skin (Marjolin’s Ulcer): still an unmet need in the era of immunotherapy. The Oncologist. https://doi.org/10.1093/oncolo/oyae326

Vancouver

Miodovnik M, Dolev Y, Buchen R, Brezis MR, Nikolaevski-Berlin A, Finkel I, et al. Squamous cell carcinoma arising in chronically damaged skin (Marjolin’s Ulcer): still an unmet need in the era of immunotherapy. The Oncologist. 2025. doi:10.1093/oncolo/oyae326

BibTeX
@article{Miodovnik2025,
  author = {Miodovnik, Mor and Dolev, Yardenna and Buchen, Roni and Brezis, Miriam Rivka and Nikolaevski-Berlin, Alla and Finkel, Inbar and Wolf, Ido and Ospovat, Inna and Gutfeld, Orit and Leshem, Yasmin},
  title = {Squamous cell carcinoma arising in chronically damaged skin (Marjolin’s Ulcer): still an unmet need in the era of immunotherapy},
  journal = {The Oncologist},
  year = {2025},
  doi = {10.1093/oncolo/oyae326}
}
Kostenlos starten →